We subcutaneously injected scrambled sgRNA control, USP29-depleted HCT116 cells, and USP29-depleted cells with reconstituted USP29 into different groups of NSG mice and monitored the tumor growth continuously for 4 weeks. The gene discussed is USP29; the disease is neoplasm.